VOYA Investment Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.1M Buy
86,257
+17,442
+25% +$1.75M 0.01% 629
2026
Q1
$6.36M Buy
68,815
+1,066
+2% +$100K 0.01% 755
2025
Q4
$5.35M Sell
67,749
-11,148
-14% -$800K 0.01% 846
2025
Q3
$5.78M Buy
78,897
+12,106
+18% +$770K 0.01% 820
2025
Q2
$3.4M Buy
66,791
+46,976
+237% +$2.09M ﹤0.01% 1098
2025
Q1
$893K Sell
19,815
-7,793
-28% -$367K ﹤0.01% 1620
2024
Q4
$1.14M Sell
27,608
-910
-3% -$37.9K ﹤0.01% 1531
2024
Q3
$1.11M Buy
28,518
+15,315
+116% +$611K ﹤0.01% 1583
2024
Q2
$451K Buy
13,203
+5,002
+61% +$131K ﹤0.01% 2065
2024
Q1
$206K Sell
8,201
-2,015
-20% -$55.4K ﹤0.01% 2439
2023
Q4
$302K Sell
10,216
-185
-2% -$5.6K ﹤0.01% 2342
2023
Q3
$329K Sell
10,401
-288
-3% -$7.89K ﹤0.01% 2262
2023
Q2
$277K Buy
+10,689
New +$284K ﹤0.01% 2414

Other funds holding MIRM

VOYA Investment Management's MIRM Position: Q2 2026 in Review

VOYA Investment Management increased its Mirum Pharmaceuticals (MIRM) stake by 25% in Q2 2026, buying an estimated $1.75M and bringing the position to 86,257 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #629.

VOYA Investment Management first reported a position in MIRM in Q2 2023 and has held it in 13 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • VOYA Investment Management held 86,257 shares of Mirum Pharmaceuticals worth $10.1M as of Q2 2026.
  • VOYA Investment Management bought 17,442 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.75M.
  • Mirum Pharmaceuticals made up 0.01% of VOYA Investment Management's portfolio in Q2 2026, its #629 holding.
  • VOYA Investment Management first reported a position in Mirum Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.